Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleHuman Study

Clinical Experience with Rhenium-186-Labeled Monoclonal Antibodies for Radioimmunotherapy: Results of Phase I Trials

Hazel B. Breitz, Paul L. Weiden, J-L Vanderheyden, Janet W. Appelbaum, Michael J. Bjorn, Mehmet F. Fer, Sandra B. Wolf, Barbara A. Ratliff, Christine A. Seiler, Debbie C. Foisie, Darrell R. Fisher, Robert W. Schroff, Alan R. Fritzberg and Paul G. Abrams
Journal of Nuclear Medicine June 1992, 33 (6) 1099-1109;
Hazel B. Breitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul L. Weiden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J-L Vanderheyden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet W. Appelbaum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Bjorn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehmet F. Fer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra B. Wolf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara A. Ratliff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine A. Seiler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debbie C. Foisie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darrell R. Fisher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert W. Schroff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan R. Fritzberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul G. Abrams
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 33 no. 6 1099-1109
PubMed 
1597723

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X

Copyright & Usage 
COPYRIGHT © 1992 by The Society of Nuclear Medicine, Inc.

Author Information

Statistics from Altmetric.com

Cited By...

  • 149 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: April 2001 to April 2025

AbstractFullPdf
Apr 2001100
Jul 2001100
Aug 2001100
Nov 2001100
Mar 2002100
May 2002100
Jun 2002100
Jan 2003100
Apr 2003800
Jun 2003200
Jul 2003600
Aug 2003500
Sep 2003200
Oct 2003700
Nov 2003900
Dec 2003600
Jan 2004900
Feb 2004500
Mar 2004600
Apr 2004800
May 20041300
Jun 20042200
Jul 20042200
Aug 20041300
Sep 2004800
Oct 2004700
Nov 2004700
Dec 2004400
Jan 2005400
Feb 2005900
Mar 2005900
Apr 2005100
May 2005200
Jul 2005300
Sep 2005100
Oct 2005200
Nov 2005800
Dec 2005200
Jan 2006400
Feb 2006100
Mar 2006500
Apr 2006200
May 2006200
Jun 2006400
Jul 2006200
Aug 2006300
Sep 2006500
Oct 2006400
Nov 2006300
Dec 2006100
Jan 2007805
Feb 2007201
Mar 2007404
Apr 2007803
May 2007302
Jun 2007305
Jul 2007202
Aug 2007202
Sep 2007202
Oct 2007504
Nov 2007106
Dec 2007409
Jan 2008504
Feb 20085010
Mar 20082014
Apr 20083012
May 20081005
Jun 20086013
Jul 2008302
Aug 2008501
Sep 2008603
Oct 2008203
Nov 20089012
Dec 2008005
Jan 2009303
Feb 2009605
Mar 2009506
Apr 2009506
May 2009203
Jun 2009101
Jul 2009105
Aug 2009304
Sep 2009603
Oct 2009205
Nov 2009905
Dec 2009105
Jan 2010206
Feb 2010402
Mar 2010902
Apr 2010105
May 2010602
Jun 20107015
Jul 2010304
Aug 2010804
Sep 2010608
Oct 2010905
Nov 201015015
Dec 20101404
Jan 2011809
Feb 20111109
Mar 20119012
Apr 2011208
May 20111005
Jun 2011007
Jul 20110017
Aug 20110017
Sep 2011008
Oct 20110014
Nov 20110011
Dec 20110011
Jan 20120016
Feb 20120015
Mar 20120017
Apr 2012007
May 20120025
Jun 20120016
Jul 2012003
Aug 2012006
Sep 20120015
Oct 2012009
Nov 2012002
Dec 2012008
Jan 2013008
Feb 2013008
Mar 2013009
Apr 2013009
May 2013009
Jun 2013005
Jul 2013001
Aug 2013005
Oct 2013001
Nov 2013003
Dec 2013003
Feb 2014004
Mar 2014001
Jun 2014003
Jul 2014001
Aug 2014002
Sep 20140010
Oct 2014003
Nov 2014003
Dec 2014003
Jan 2015002
Feb 20150015
Mar 20150021
Apr 20150017
May 20150018
Jun 2015009
Jul 20150025
Aug 2015005
Sep 2015006
Oct 2015009
Nov 20150014
Dec 20150012
Jan 20160017
Feb 20160015
Mar 20160010
Apr 20160013
May 20160020
Jun 20160017
Jul 20160019
Aug 2016004
Sep 2016007
Oct 2016007
Nov 20160122
Dec 20160010
Jan 20170013
Feb 2017005
Mar 20170010
Apr 2017009
May 20170013
Jun 20170015
Jul 20170011
Aug 20170017
Sep 2017005
Oct 2017008
Nov 20170014
Dec 2017006
Jan 2018007
Feb 20180013
Mar 20180015
Apr 2018008
May 20180023
Jun 2018003
Jul 2018003
Aug 2018001
Sep 20180010
Oct 20180013
Nov 20180011
Dec 20180012
Jan 20190014
Feb 20190019
Mar 20190027
Apr 20190011
May 2019009
Jun 2019007
Jul 20190017
Aug 2019006
Sep 20190025
Oct 2019005
Nov 2019006
Dec 2019009
Jan 2020004
Feb 2020003
Mar 2020005
Apr 2020009
May 2020006
Jun 2020001
Jul 2020004
Aug 20200015
Sep 20200010
Oct 20200016
Nov 2020007
Dec 20200013
Jan 2021209
Feb 2021107
Mar 20212015
Apr 2021007
May 20210013
Jun 20211014
Jul 20210013
Aug 20212015
Sep 20211015
Oct 2021103
Nov 20210030
Dec 20210012
Jan 20221025
Feb 2022104
Mar 2022205
Apr 2022004
May 2022105
Jun 2022006
Jul 2022004
Aug 2022004
Sep 2022006
Oct 2022101
Nov 2022004
Dec 2022003
Jan 2023008
Feb 2023005
Mar 2023005
Apr 2023004
May 2023001
Jul 2023006
Aug 2023002
Sep 2023001
Oct 2023003
Nov 2023202
Dec 2023105
Jan 2024104
Feb 2024102
Mar 2024001
Apr 2024206
May 20243011
Jun 20244011
Jul 2024009
Aug 20243013
Sep 2024102
Oct 2024008
Nov 2024105
Dec 2024004
Jan 2025506
Feb 20250010
Mar 2025105
Apr 20250015
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 33, Issue 6
June 1, 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Experience with Rhenium-186-Labeled Monoclonal Antibodies for Radioimmunotherapy: Results of Phase I Trials
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Clinical Experience with Rhenium-186-Labeled Monoclonal Antibodies for Radioimmunotherapy: Results of Phase I Trials
Hazel B. Breitz, Paul L. Weiden, J-L Vanderheyden, Janet W. Appelbaum, Michael J. Bjorn, Mehmet F. Fer, Sandra B. Wolf, Barbara A. Ratliff, Christine A. Seiler, Debbie C. Foisie, Darrell R. Fisher, Robert W. Schroff, Alan R. Fritzberg, Paul G. Abrams
Journal of Nuclear Medicine Jun 1992, 33 (6) 1099-1109;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical Experience with Rhenium-186-Labeled Monoclonal Antibodies for Radioimmunotherapy: Results of Phase I Trials
Hazel B. Breitz, Paul L. Weiden, J-L Vanderheyden, Janet W. Appelbaum, Michael J. Bjorn, Mehmet F. Fer, Sandra B. Wolf, Barbara A. Ratliff, Christine A. Seiler, Debbie C. Foisie, Darrell R. Fisher, Robert W. Schroff, Alan R. Fritzberg, Paul G. Abrams
Journal of Nuclear Medicine Jun 1992, 33 (6) 1099-1109;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer
  • 186Rhenium-labeled anti-CD20 antibody radioimmunotherapy followed by autologous peripheral blood stem cell transplantation in patients with relapsed or refractory non-Hodgkin lymphoma
  • A Phase I Trial of 90Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer
  • Pretargeted Radioimmunotherapy of Cancer: Progress Step by Step
  • How Far Have We Come with Solid (Nonhematologic) Tumor Radioimmunotherapy?
  • Phase I Therapy Study of 186Re-Labeled Chimeric Monoclonal Antibody U36 in Patients with Squamous Cell Carcinoma of the Head and Neck
  • Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity
  • Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer
  • Phase I Study of 90Y-labeled B72.3 Intraperitoneal Administration in Patients with Ovarian Cancer: Effect of Dose and EDTA Coadministration on Pharmacokinetics and Toxicity
  • Molecular Modeling and Preclinical Evaluation of the Humanized NR-LU-13 Antibody
  • Google Scholar

More in this TOC Section

  • Nodal Spread of Squamous Cell Carcinoma of the Oral Cavity Detected with PET-Tyrosine, MRI and CT
  • Simplified Measurement of Deoxyglucose Utilization Rate
  • Technetium-99m-Sestamibi Scintigraphy Compared with Thallium-201 in Evaluation of Thyroid Tumors
Show more Human Study

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire